Opinion|Videos|March 18, 2025
Evolution of Oncology Pharmacy Practice in mCRC
Experts discuss how the role of oncology pharmacists in managing metastatic colorectal cancer (mCRC) has evolved, particularly in enabling medication adjustments, refills, and prescribing supportive care medications, and explore the impact of this expanded role on patient outcomes and how pharmacists can leverage medication knowledge to optimize treatment and patient care further.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How has the role of oncology pharmacists in managing mCRC evolved, particularly in enabling medication adjustments, refills, and prescribing supportive care medications?
- What impact has this expanded role had on patient outcomes?
- In what ways can pharmacists leverage medication knowledge to optimize treatment and patient care for mCRC further?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
5